DK1141305T3 - Kimært gen som koder for de antigene determinanter af fire proteiner af L. infantum - Google Patents

Kimært gen som koder for de antigene determinanter af fire proteiner af L. infantum

Info

Publication number: DK1141305T3
Authority: DK; Denmark
Prior art keywords: proteins; gene encoding; chimeric gene; infantum; antigenic determinants
Prior art date: 1998-12-23

Application number

DK99967987T

Other languages

Danish (da)

English (en)

Inventor

Alonso Carlos Bedate

Original Assignee

Leti Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-23

Filing date

1999-12-23

Publication date

2006-09-25

1998-12-23 Priority claimed from CA2256124A external-priority patent/CA2256124C/fr

1999-12-23 Application filed by Leti Lab filed Critical Leti Lab

2006-09-25 Application granted granted Critical

2006-09-25 Publication of DK1141305T3 publication Critical patent/DK1141305T3/da

Links

108090000623 proteins and genes Proteins 0.000 title abstract 4
241000222697 Leishmania infantum Species 0.000 title abstract 2
230000000890 antigenic effect Effects 0.000 title abstract 2
102000004169 proteins and genes Human genes 0.000 title abstract 2
206010047505 Visceral leishmaniasis Diseases 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 2
208000004554 Leishmaniasis Diseases 0.000 abstract 1
102000037865 fusion proteins Human genes 0.000 abstract 1
108020001507 fusion proteins Proteins 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Tropical Medicine & Parasitology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK99967987T 1998-12-23 1999-12-23 Kimært gen som koder for de antigene determinanter af fire proteiner af L. infantum DK1141305T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11382598P	1998-12-23	1998-12-23
CA2256124A CA2256124C (fr)	1998-12-23	1998-12-23	Gene chimere forme de sequences d'adn codant pour les sites antigeniques de quatre proteines de l. infantum, proteine codee par le gene en question et composition pharmaceutique utile pour prevenir et/ou traiter la leishmaniose chez les animaux ou les humains

Publications (1)

Publication Number	Publication Date
DK1141305T3 true DK1141305T3 (da)	2006-09-25

Family

ID=25680668

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99967987T DK1141305T3 (da)	1998-12-23	1999-12-23	Kimært gen som koder for de antigene determinanter af fire proteiner af L. infantum

Country Status (22)

Country	Link
EP (1)	EP1141305B1 (fr)
CN (1)	CN1158387C (fr)
AT (2)	ATE327332T1 (fr)
AU (1)	AU759316B2 (fr)
BE (1)	BE2016C049I2 (fr)
BG (1)	BG65569B1 (fr)
BR (1)	BRPI9916549B8 (fr)
CY (3)	CY1105331T1 (fr)
CZ (1)	CZ20012360A3 (fr)
DE (2)	DE69940793D1 (fr)
DK (1)	DK1141305T3 (fr)
ES (2)	ES2273519T3 (fr)
HR (1)	HRP20010554A2 (fr)
HU (1)	HUP0104743A3 (fr)
IL (2)	IL143956A0 (fr)
LU (1)	LU93259I2 (fr)
MX (1)	MXPA01006548A (fr)
NL (1)	NL300830I2 (fr)
PT (2)	PT1624063E (fr)
SI (1)	SI1624063T1 (fr)
TR (1)	TR200102655T2 (fr)
WO (1)	WO2000039298A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6613337B1 (en) *	1997-02-12	2003-09-02	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ES2169995B1 (es) *	2000-04-17	2003-12-01	Leti Lab	Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
US6673351B1 (en)	2001-03-16	2004-01-06	Astralis, Llc	Compositions and methods for the treatment and clinical remission of psoriasis
WO2006058243A2 (fr) *	2004-11-24	2006-06-01	Yale University	Antigenes de leishmania, compositions apparentees et utilisations correspondantes
WO2009090175A1 (fr) *	2008-01-18	2009-07-23	Laboratorios Leti, S.L. Unipersonal	Vaccin comprenant un extrait de protéine ribosomale (rpe) et facultativement un adjuvant promouvant la réponse th1
RU2558233C2 (ru) *	2009-07-13	2015-07-27	Лабораториос Лети, С.Л.	Диагностика паразитарного заболевания, такого как лейшманиоз, с использованием экстракта рибосомальных белков (rpe)
SA110310855B1 (ar)	2009-11-13	2014-09-16	Laboratories Leti S L Unipersonal	استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
BR102019003639A2 (pt) *	2019-02-22	2021-11-16	Fundação Oswaldo Cruz	Proteína quimérica, seu método para produção e uso, bem como molécula de ácido nucleico, cassete de expressão, vetor de expressão, célula hospedeira, composição para diagnóstico de leishmaniose, kit de diagnóstico de leishmaniose e método de diagnóstico de leishmaniose in vitro
ES2795149B2 (es)	2020-06-08	2022-07-04	Univ Madrid Complutense	Quimera sintetica multiepitopica como vacuna y tratamiento frente a leishmaniosis en mamiferos
CN112662694A (zh) *	2020-12-25	2021-04-16	康九生物科技(长春)有限公司	一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0703295A1 (fr) *	1994-09-26	1996-03-27	Institut Pasteur	Vaccin comprenant un BCG recombinant exprimant une protéine de fusion de GP63
US5912166A (en) *	1995-04-21	1999-06-15	Corixa Corporation	Compounds and methods for diagnosis of leishmaniasis
ES2133236B1 (es) *	1997-06-27	2000-04-16	Leti Lab	Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida.

1999
- 1999-12-23 ES ES99967987T patent/ES2273519T3/es not_active Expired - Lifetime
- 1999-12-23 DK DK99967987T patent/DK1141305T3/da active
- 1999-12-23 DE DE69940793T patent/DE69940793D1/de not_active Expired - Lifetime
- 1999-12-23 AT AT99967987T patent/ATE327332T1/de active
- 1999-12-23 PT PT05109393T patent/PT1624063E/pt unknown
- 1999-12-23 ES ES05109393T patent/ES2326174T3/es not_active Expired - Lifetime
- 1999-12-23 HU HU0104743A patent/HUP0104743A3/hu unknown
- 1999-12-23 MX MXPA01006548A patent/MXPA01006548A/es active IP Right Grant
- 1999-12-23 EP EP99967987A patent/EP1141305B1/fr not_active Expired - Lifetime
- 1999-12-23 IL IL14395699A patent/IL143956A0/xx unknown
- 1999-12-23 AU AU24342/00A patent/AU759316B2/en not_active Expired
- 1999-12-23 CZ CZ20012360A patent/CZ20012360A3/cs unknown
- 1999-12-23 PT PT99967987T patent/PT1141305E/pt unknown
- 1999-12-23 DE DE69931518T patent/DE69931518T2/de not_active Expired - Lifetime
- 1999-12-23 BR BRPI9916549A patent/BRPI9916549B8/pt not_active IP Right Cessation
- 1999-12-23 AT AT05109393T patent/ATE429498T1/de not_active IP Right Cessation
- 1999-12-23 TR TR2001/02655T patent/TR200102655T2/xx unknown
- 1999-12-23 CN CNB998163066A patent/CN1158387C/zh not_active Expired - Lifetime
- 1999-12-23 HR HR20010554A patent/HRP20010554A2/hr not_active Application Discontinuation
- 1999-12-23 SI SI9931029T patent/SI1624063T1/sl unknown
- 1999-12-23 WO PCT/EP1999/010441 patent/WO2000039298A1/fr not_active Ceased
2001
- 2001-06-24 IL IL143956A patent/IL143956A/en not_active IP Right Cessation
- 2001-07-23 BG BG105725A patent/BG65569B1/bg unknown
2006
- 2006-08-24 CY CY20061101190T patent/CY1105331T1/el unknown
2009
- 2009-07-14 CY CY20091100739T patent/CY1109221T1/el unknown
2016
- 2016-09-22 NL NL300830C patent/NL300830I2/nl unknown
- 2016-10-06 BE BE2016C049C patent/BE2016C049I2/nl unknown
- 2016-10-06 LU LU93259C patent/LU93259I2/fr unknown
- 2016-10-20 CY CY2016033C patent/CY2016033I2/el unknown

Also Published As

Publication number	Publication date
SI1624063T1 (sl)	2009-08-31
NL300830I2 (nl)	2020-08-31
CY1109221T1 (el)	2014-07-02
AU2434200A (en)	2000-07-31
CN1335889A (zh)	2002-02-13
IL143956A0 (en)	2002-04-21
EP1141305B1 (fr)	2006-05-24
IL143956A (en)	2010-11-30
AU759316B2 (en)	2003-04-10
PT1624063E (pt)	2009-06-19
DE69931518D1 (de)	2006-06-29
BRPI9916549B8 (pt)	2022-08-30
DE69940793D1 (de)	2009-06-04
CY2016033I1 (el)	2017-03-15
TR200102655T2 (tr)	2002-04-22
BRPI9916549B1 (pt)	2018-10-02
BE2016C049I2 (fr)	2019-03-05
ATE327332T1 (de)	2006-06-15
WO2000039298A1 (fr)	2000-07-06
CN1158387C (zh)	2004-07-21
BG105725A (en)	2002-06-28
HUP0104743A2 (hu)	2002-03-28
CY2016033I2 (el)	2017-03-15
NL300830I1 (nl)	2016-09-28
ES2273519T3 (es)	2007-05-01
CZ20012360A3 (cs)	2001-10-17
ES2326174T3 (es)	2009-10-02
CY1105331T1 (el)	2010-03-03
ATE429498T1 (de)	2009-05-15
LU93259I2 (fr)	2016-12-06
MXPA01006548A (es)	2003-03-27
BG65569B1 (bg)	2008-12-30
PT1141305E (pt)	2006-10-31
EP1141305A1 (fr)	2001-10-10
BR9916549A (pt)	2005-01-04
HRP20010554A2 (en)	2002-08-31
HUP0104743A3 (en)	2004-10-28
DE69931518T2 (de)	2006-12-21

Publication	Publication Date	Title
LU93259I2 (fr)	2016-12-06	LETIFEND (Protein Q)
IL189629A0 (en)	2008-06-05	Compositions containing human ctla-4 antibodies
YU79202A (sh)	2006-01-16	Peptid koji modulira trombopoetinski receptor
WO1999014241A3 (fr)	1999-06-10	Traitement d'affections liees aux fonctions immunitaires et compositions correspondantes
FI972170A7 (fi)	1997-05-21	Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, n äitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö
MXPA04001986A (es)	2004-06-07	Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
ATE315092T1 (de)	2006-02-15	Acetylhydrolase des plättchen aktivierenden faktors, und entsprechendes gen
DK0975360T3 (da)	2006-11-27	Bovint respiratorisk og enterisk coronavirus som vaccine
WO2001040465A3 (fr)	2002-03-21	Compositions et procedes de traitement de maladies d'ordre immunologique
YU51601A (sh)	2005-07-19	Himerni gen koji kodira antigene determinante četiri proteina l.infantum
ATE346091T1 (de)	2006-12-15	Neues diagnostisches reagens und kit zur erkennung von rickettsiose
DE69830156D1 (de)	2005-06-16	Zusammensetzungen zur immunverstärkung von impfstoffen
WO2001066740A3 (fr)	2002-09-19	Compositions et methodes de traitement de maladies d'origine immune
AU7079300A (en)	2001-03-26	Compositions and methods for the treatment of immune related diseases
DE60129228D1 (de)	2007-08-16	Humane 7-transmembranproteine und dafür codierende polynukleotide
ES2191785T3 (es)	2003-09-16	Proteina de accion antitumoral.
FI952111A7 (fi)	1995-11-06	Trifluorimetyyliketoneista johdetut uudet peptidit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
ZA958878B (en)	1996-05-21	Nucleotide sequence encoding antigens of HIV-1 retroviruses proteins and peptides derived therefrom